Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Improvement of oxidative and metabolic parameters by cellfood administration in patients affected by neurodegenerative diseases on chelation treatment.

Fulgenzi A, Giuseppe RD, Bamonti F, Ferrero ME.

Biomed Res Int. 2014;2014:281510. doi: 10.1155/2014/281510. Epub 2014 Jul 10.

PMID:
25114898
[PubMed - in process]
Free PMC Article
2.

Defibrotide: properties and clinical use of an old/new drug.

Pescador R, Capuzzi L, Mantovani M, Fulgenzi A, Ferrero ME.

Vascul Pharmacol. 2013 Jul-Aug;59(1-2):1-10. doi: 10.1016/j.vph.2013.05.001. Epub 2013 May 14. Review.

PMID:
23680861
[PubMed - indexed for MEDLINE]
Free Article
3.

P2X7 receptor is expressed in human vessels and might play a role in atherosclerosis.

Piscopiello M, Sessa M, Anzalone N, Castellano R, Maisano F, Ferrero E, Chiesa R, Alfieri O, Comi G, Ferrero ME, Foglieni C.

Int J Cardiol. 2013 Oct 3;168(3):2863-6. doi: 10.1016/j.ijcard.2013.03.084. Epub 2013 Apr 17. No abstract available.

PMID:
23602287
[PubMed - in process]
4.

Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.

Vergani A, Fotino C, D'Addio F, Tezza S, Podetta M, Gatti F, Chin M, Bassi R, Molano RD, Corradi D, Gatti R, Ferrero ME, Secchi A, Grassi F, Ricordi C, Sayegh MH, Maffi P, Pileggi A, Fiorina P.

Diabetes. 2013 May;62(5):1665-75. doi: 10.2337/db12-0242. Epub 2013 Jan 11.

PMID:
23315496
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7.

Vergani A, Tezza S, D'Addio F, Fotino C, Liu K, Niewczas M, Bassi R, Molano RD, Kleffel S, Petrelli A, Soleti A, Ammirati E, Frigerio M, Visner G, Grassi F, Ferrero ME, Corradi D, Abdi R, Ricordi C, Sayegh MH, Pileggi A, Fiorina P.

Circulation. 2013 Jan 29;127(4):463-75. doi: 10.1161/CIRCULATIONAHA.112.123653. Epub 2012 Dec 18.

PMID:
23250993
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A case of multiple sclerosis improvement following removal of heavy metal intoxication: lessons learnt from Matteo's case.

Fulgenzi A, Zanella SG, Mariani MM, Vietti D, Ferrero ME.

Biometals. 2012 Jun;25(3):569-76. doi: 10.1007/s10534-012-9537-7. Epub 2012 Mar 22.

PMID:
22438029
[PubMed - indexed for MEDLINE]
7.

Ozonated autohemotherapy: protection of kidneys from ischemia in rats subjected to unilateral nephrectomy.

Foglieni C, Fulgenzi A, Belloni D, Sciorati C, Ferrero E, Ferrero ME.

BMC Nephrol. 2011 Nov 14;12:61. doi: 10.1186/1471-2369-12-61.

PMID:
22081953
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cellfood™ improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced reactive oxygen species (ros) generation.

Ferrero E, Fulgenzi A, Belloni D, Foglieni C, Ferrero ME.

J Physiol Pharmacol. 2011 Jun;62(3):287-93.

PMID:
21893688
[PubMed - indexed for MEDLINE]
Free Article
9.

Mn bioavailability by polarized Caco-2 cells: comparison between Mn gluconate and Mn oxyprolinate.

Foglieni C, Cavarelli M, Piscopiello M, Fulgenzi A, Ferrero ME.

Nutr J. 2011 Jul 25;10:77. doi: 10.1186/1475-2891-10-77.

PMID:
21781350
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Metal chelation therapy in rheumathoid arthritis: a case report. Successful management of rheumathoid arthritis by metal chelation therapy.

Bamonti F, Fulgenzi A, Novembrino C, Ferrero ME.

Biometals. 2011 Dec;24(6):1093-8. doi: 10.1007/s10534-011-9467-9. Epub 2011 Jun 8.

PMID:
21655943
[PubMed - indexed for MEDLINE]
11.

Purinoceptors in inflammation: potential as anti-inflammatory therapeutic targets.

Ferrero ME.

Front Biosci (Landmark Ed). 2011 Jun 1;16:2172-86. Review.

PMID:
21622169
[PubMed - indexed for MEDLINE]
12.

Phylogeography and genetic structure of the red-legged partridge (Alectoris rufa): more evidence for refugia within the Iberian glacial refugium.

Ferrero ME, Blanco-Aguiar JA, Lougheed SC, Sánchez-Barbudo I, De Nova PJ, Villafuerte R, Dávila JA.

Mol Ecol. 2011 Jun;20(12):2628-42. doi: 10.1111/j.1365-294X.2011.05111.x. Epub 2011 May 3.

PMID:
21535277
[PubMed - indexed for MEDLINE]
13.

The usefulness of chelation therapy for the remission of symptoms caused by previous treatment with mercury-containing pharmaceuticals: a case report.

Corsello S, Fulgenzi A, Vietti D, Ferrero ME.

Cases J. 2009 Nov 18;2:199. doi: 10.1186/1757-1626-2-199.

PMID:
19946446
[PubMed]
Free PMC Article
14.

Permanent Genetic Resources added to Molecular Ecology Resources database 1 January 2009-30 April 2009.

Molecular Ecology Resources Primer Development Consortium, Abercrombie LG, Anderson CM, Baldwin BG, Bang IC, Beldade R, Bernardi G, Boubou A, Branca A, Bretagnolle F, Bruford MW, Buonamici A, Burnett RK Jr, Canal D, Cárdenas H, Caullet C, Chen SY, Chun YJ, Cossu C, Crane CF, Cros-Arteil S, Cudney-Bueno R, Danti R, Dávila JA, Della Rocca G, Dobata S, Dunkle LD, Dupas S, Faure N, Ferrero ME, Fumanal B, Gigot G, González I, Goodwin SB, Groth D, Hardesty BD, Hasegawa E, Hoffman EA, Hou ML, Jamsari AF, Ji HJ, Johnson DH, Joseph L, Justy F, Kang EJ, Kaufmann B, Kim KS, Kim WJ, Koehler AV, Laitung B, Latch P, Liu YD, Manjerovic MB, Martel E, Metcalfe SS, Miller JN, Midgley JJ, Migeon A, Moore AJ, Moore WL, Morris VR, Navajas M, Navia D, Neel MC, De Nova PJ, Olivieri I, Omura T, Othman AS, Oudot-Canaff J, Panthee DR, Parkinson CL, Patimah I, Pérez-Galindo CA, Pettengill JB, Pfautsch S, Piola F, Potti J, Poulin R, Raimondi PT, Rinehart TA, Ruzainah A, Sarver SK, Scheffler BE, Schneider AR, Silvain JF, Siti Azizah MN, Springer YP, Stewart CN, Sun W, Tiedemann R, Tsuji K, Trigiano RN, Vendramin GG, Wadl PA, Wang L, Wang X, Watanabe K, Waterman JM, Weisser WW, Westcott DA, Wiesner KR, Xu XF, Yaegashi S, Yuan JS.

Mol Ecol Resour. 2009 Sep;9(5):1375-9. doi: 10.1111/j.1755-0998.2009.02746.x. Epub 2009 Jul 17.

PMID:
21564911
[PubMed]
15.

A new approach to the inflammatory/autoimmune diseases.

Ferrero ME.

Recent Pat Antiinfect Drug Discov. 2009 Jun;4(2):108-13. Review.

PMID:
19519545
[PubMed - indexed for MEDLINE]
16.

Rationale of the combined use of inspiratory and expiratory devices in improving maximal inspiratory pressure and maximal expiratory pressure of patients with chronic obstructive pulmonary disease.

Battaglia E, Fulgenzi A, Ferrero ME.

Arch Phys Med Rehabil. 2009 Jun;90(6):913-8. doi: 10.1016/j.apmr.2008.12.019.

PMID:
19480865
[PubMed - indexed for MEDLINE]
17.

Unexpected perinatal loss versus Sids-a common neuropathologic entity.

Matturri L, Mauri M, Ferrero ME, Lavezzi AM.

Open Neurol J. 2008;2:45-50. doi: 10.2174/1874205X00802010045. Epub 2008 Sep 5.

PMID:
19018308
[PubMed]
Free PMC Article
18.

Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy.

Fulgenzi A, Ticozzi P, Gabel CA, Dell'Antonio G, Quattrini A, Franzone JS, Ferrero ME.

Int J Immunopathol Pharmacol. 2008 Jan-Mar;21(1):61-71.

PMID:
18336732
[PubMed - indexed for MEDLINE]
19.

Cracked mercury dental amalgam as a possible cause of fever of unknown origin: a case report.

Bamonti F, Guzzi G, Ferrero ME.

J Med Case Rep. 2008 Mar 6;2:72. doi: 10.1186/1752-1947-2-72.

PMID:
18325096
[PubMed]
Free PMC Article
20.

The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.

Belloni D, Scabini S, Foglieni C, Veschini L, Giazzon A, Colombo B, Fulgenzi A, Helle KB, Ferrero ME, Corti A, Ferrero E.

FASEB J. 2007 Oct;21(12):3052-62. Epub 2007 Jun 12.

PMID:
17566084
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk